Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

CAS TSIS TAU: 1448326-33-7
Cov Qauv Nqaij: C13H10BrCl2FN2O
Molecular Luj: 380.04
EINECS TSIS MUAJ: N / A
MDL TSIS TAU: MFCD28099329
Khoom Qhia:
Khoom npe: 3 - ((R) -1- (2,6-dichloro-3-fluorophenyl) ethoxy) -5-bromopyridin-2-amine CAS TSIS: 1448326-33-7
Txhais:
5-Bromo-3 - [(1S) -1- (2,6-dichloro-3-fluorophenyl) ethoxy] -2-pyridinamine;
(S) -5-bromo-3- (1- (2,6-dichloro-3-fluorophenyl) ethoxy) pyridin-2-amine;
Tshuaj& Cov Khoom Uas Lub Cev:
Zog: cov hmoov dawb dawb
Ntsuas:≥99.0%
Qhov ceev: 1.6g / cm3
Lub Ntsiab Lus Boiling: 423.4℃ntawm 760 mmHg
Flash Point: 209.9℃
Crizotinib nrab.
Crizotinib yog ob qho kev coj ua me me molecule tyrosine kinase receptor inhibitor tsom rau mesenchymal-epithelial kev hloov pauv (MET) thiab ALK. Nws lub hom phiaj ntawm kev nqis tes ua hauv NSCLC yog ALK tyrosine Acid kinase receptor. Zoo ib yam li EGFR inhibitor gefitinib, crizotinib inhibits kev ua haujlwm ntawm kinase los ntawm kev cuam tshuam ntawm txoj kev khi ntawm ALK kinase thiab ATP hauv NSCLC thiab autophosphorylation tom qab ua ke ntawm ob, yog li txo kinase kev ua si thiab ua si tawm tsam cov qog ua haujlwm.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov hu rau peb!
Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.
Cim npe nrov: 3 - ((r) -1- (2,6-dichloro-3-fluorophenyl) ethoxy) -5-bromopyridin-2-amine cas 1448326-33-7, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag